Keith J Kendall Aquestive Therapeutics, Inc. (AQST) insider trading activity

AQST Quotes by TradingView

Keith J Kendall is CEO and President of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 636,149 shares of AQST, which is worth approximately $2.25 Million. The most recent transaction as insider was on Aug 26, 2021, when has been sold 1,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 636K
0% 3M change
0% 12M change
Total Value Held $2.25 Million

Keith J Kendall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2021
SELL
Bona fide gift
-
1,000 Reduced 0.16%
636,149 Common Stock
Dec 30 2020
SELL
Bona fide gift
-
2,000 Reduced 0.31%
637,149 Common Stock

Also insider at

FEMY
FEMASYS INC Healthcare
KJK

Keith J Kendall

CEO and President
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AQST